#  @Celltrioninc Celltrion Celltrion posts on X about breaking news, release, global, $068270ks the most. They currently have [---] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours. ### Engagements: undefined [#](/creator/twitter::1405775970217324545/interactions)  - [--] Week [--] +48% - [--] Month [---] +51% - [--] Months [-----] +14% - [--] Year [-----] -77% ### Mentions: undefined [#](/creator/twitter::1405775970217324545/posts_active)  - [--] Months [--] -11% - [--] Year [--] +173% ### Followers: [---] [#](/creator/twitter::1405775970217324545/followers)  - [--] Week [---] -0.26% - [--] Month [---] +1% - [--] Months [---] +4.30% - [--] Year [---] +20% ### CreatorRank: undefined [#](/creator/twitter::1405775970217324545/influencer_rank)  ### Social Influence **Social category influence** [travel destinations](/list/travel-destinations) [countries](/list/countries) [finance](/list/finance) [stocks](/list/stocks) [financial services](/list/financial-services) **Social topic influence** [breaking news](/topic/breaking-news), [release](/topic/release), [global](/topic/global), [$068270ks](/topic/$068270ks), [paris](/topic/paris), [future](/topic/future), [breaking](/topic/breaking), [in the](/topic/in-the), [amsterdam](/topic/amsterdam), [share](/topic/share) **Top accounts mentioned or mentioned by** [@bbcstoryworks](/creator/undefined) [@eucommission](/creator/undefined) [@emanews](/creator/undefined) [@uicc](/creator/undefined) ### Top Social Posts Top posts by engagements in the last [--] hours "#NationalWomensEqualityDay marks a turning point in the history of the struggle for equal treatment of women and womens rights. We'd like to celebrate this day introducing our female leaders who accelerate their careers with great accomplishments. #BreakingTheBoundaries" [X Link](https://x.com/Celltrioninc/status/1694640229066662330) 2023-08-24T09:18Z [---] followers, [---] engagements "We are excited to share that we will be participating in #PANLAR2024 Annual Congress this week in Barranquilla Colombia We will be discussing our work to address the unmet needs for patients living with rheumatic disease in Latin America. #Rheumatology" [X Link](https://x.com/Celltrioninc/status/1777611762277175337) 2024-04-09T08:17Z [---] followers, [--] engagements "BREAKING NEWS: We are thrilled to announce the EC approval of the first and only #omalizumab #biosimilar approved in Europe that will help to increase access to needed medicines. This milestone shines a light on the importance of biosimilars and our commitment to providing patient-centric approaches to care for allergic diseases in Europe. Find out more at: https://shorturl.at/YLIvh https://shorturl.at/YLIvh" [X Link](https://x.com/Celltrioninc/status/1793858446481391691) 2024-05-24T04:15Z [---] followers, [--] engagements "Embark on a #WheresCC journey to Hungary & Poland 🌍✈ Uncover the hurdles faced by IBD patients due to strict diagnostic criteria. Let's unite for accessible care 🤝 Spot CC and join the cause at 💡 #IBDHasNoBorders http://www.WhereisCC.com http://www.WhereisCC.com" [X Link](https://x.com/Celltrioninc/status/1797878884790390924) 2024-06-04T06:31Z [---] followers, 32.9K engagements "BREAKING NEWS: We are pleased to announce the EC approval of an #ustekinumab #biosimilar. This approval represents a significant milestone as we aim to lead the way in providing patient-centric care for autoimmune diseases. View press release here: https://shorturl.at/Y3mTF https://shorturl.at/Y3mTF" [X Link](https://x.com/Celltrioninc/status/1827855914126426269) 2024-08-25T23:49Z [---] followers, [---] engagements "Celltrion will be attending the Morgan Stanley 22nd Annual Global Healthcare Conference in New York. #Savethedate as our Chairman and CEO will be presenting at a fireside chat on Friday September [--]. Learn more at: https://shorturl.at/X9KcB https://shorturl.at/X9KcB" [X Link](https://x.com/Celltrioninc/status/1828587418792141217) 2024-08-28T00:16Z [---] followers, [---] engagements "Following the European Commissions approval of #ustekinumab #biosimilar in Europe Taehun Ha Senior Vice President and Head of Europe Division at Celltrion shares the significance of this milestone for patients with multiple chronic inflammatory diseases" [X Link](https://x.com/Celltrioninc/status/1828970129612538182) 2024-08-29T01:37Z [---] followers, [---] engagements "Celltrion is heading to #ERSCongress2024 Join us in Vienna to hear about our advancements in #respiratory disease care. 📅 When Saturday September [--] Wednesday September [--] 📍 Where Booth C4 Exhibition Hall B RX Messe Wien" [X Link](https://x.com/Celltrioninc/status/1829318554086518980) 2024-08-30T00:41Z [---] followers, [---] engagements "We are excited to be attending #WAC2024 this week. Join us in Lisbon where well share more on our progress in advancing care for people living with allergic diseases. 📅 Friday September [--] Sunday September [--] 📍 Exhibition Hall Estoril Congress Center" [X Link](https://x.com/Celltrioninc/status/1838433952996168143) 2024-09-24T04:23Z [---] followers, [---] engagements "Celltrion will be at #UEGWeek [----] #SaveTheDate and connect with us. See you in Vienna 📅 When Saturday October [--] Tuesday October [--] 📍 Where Booth [--] Hall B Messe Wien Vienna Austria #Gastroenterology #crohnsdisease #ulcerativecolitis" [X Link](https://x.com/Celltrioninc/status/1841400369374720112) 2024-10-02T08:50Z [---] followers, [--] engagements "In our #RewritingCancer video produced by @BBCStoryWorks we delve into the experiences of Emma Foreman Consultant Pharmacist at The Royal Marsden and Jung Jin Seo Chairman Celltrion. Learn how #biosimilars could help more patients access the treatments they need and rewrite the outcomes of cancer" [X Link](https://x.com/Celltrioninc/status/1841986060290834572) 2024-10-03T23:37Z [---] followers, [---] engagements "Join us on site at this years #UEGWeek Meet The Expert session at Celltrion booth (Hall B). 📌 Meet Prof. Dr. Stefan Schreiber on Sunday [--] October 13:00-13:30 CEST 📌 Meet Dr. Angela Variola on Monday [--] October 14:00-14:30 CEST #UEGW2024 #MeetTheExperts" [X Link](https://x.com/Celltrioninc/status/1843566786182295961) 2024-10-08T08:19Z [---] followers, [---] engagements "Greetings from Vienna #UEGWeek [----] began on Saturday Make sure to stop by booth [--] and learn more about our work in #gastroenterology and our goal to address the unmet needs of GI patients. 😊" [X Link](https://x.com/Celltrioninc/status/1845715388518322404) 2024-10-14T06:36Z [---] followers, [---] engagements "Today we announced our Q3 [----] earnings release. Read full report https://bit.ly/4dBPTLc https://bit.ly/4dBPTLc" [X Link](https://x.com/Celltrioninc/status/1854815629074678087) 2024-11-08T09:18Z [---] followers, [--] engagements "Today we announce the successful acquisition of iQone Healthcare Switzerland a specialty pharmaceutical company focused on sales marketing and distribution in Switzerland. This strategic acquisition will further solidify our market presence and portfolio expediting our direct sales capabilities. For more details please view the press release here: http://bit.ly/4hRheeW http://bit.ly/4hRheeW" [X Link](https://x.com/Celltrioninc/status/1857222332005376366) 2024-11-15T00:41Z [---] followers, [--] engagements "We're excited to launch a new video featuring distinguished physicians around the world. In this video Prof. Jens Schreiber MD Head of Clinics for Pneumonology at University Hospital Magdeburg explains what a #biosimilar is" [X Link](https://x.com/Celltrioninc/status/1863762446399438954) 2024-12-03T01:49Z [---] followers, [--] engagements "#Biosimilars undergo a rigorous process to be approved by regulatory authorities. During the process extrapolation plays a very important role in providing the data needed to prove the quality of the drug. Hear from Prof. Joo Manuel Braz Gonalves Full Professor in Faculty of Pharmacy at Universidade de Lisboa about the importance of extrapolation in regulatory approval of biosimilars" [X Link](https://x.com/Celltrioninc/status/1867368257642279219) 2024-12-13T00:37Z [---] followers, [--] engagements "📢 Celltrion will be attending the J.P. Morgan 43rd Annual Healthcare Conference in San Francisco California. #Savethedate as our Chairman and CEO will be presenting at the main track on Tuesday [--] January. 📅 Tuesday January [--] at 5:15 p.m. PST 📍 Grand Ballroom The Westin St. Francis San Francisco California #DaringToGoBeyond" [X Link](https://x.com/Celltrioninc/status/1878638218654216369) 2025-01-13T03:00Z [---] followers, [---] engagements "🌟 Transforming the Future of Crohns Disease 🌟 Celltrion is proud to join the #INTERCEPT_IHI project Europes first-ever trial using innovative #biomarkers to prevent the onset of #CrohnsDisease as a partner. 🎉 📍 Save the date for the official kick-off in Berlin Germany on 19th February [----] #MedicalInnovation #PreventCrohns #FutureOfHealth #HealthcareLeadership" [X Link](https://x.com/Celltrioninc/status/1881991003521040736) 2025-01-22T09:03Z [---] followers, [---] engagements "BREAKING NEWS: We are thrilled to announce that the @EU_Commission granted marketing authorization for our two #biosimilars in the European market. This announcement further expands Celltrions diverse biosimilar portfolio. We are committed to providing patient-centric care across multiple therapeutic areas in Europe. View the press release here: https://bit.ly/3QlLpyF https://bit.ly/3QlLpyF" [X Link](https://x.com/Celltrioninc/status/1892072693161418762) 2025-02-19T04:44Z [---] followers, [--] engagements "We are excited to launch our first on-site congress activity of [----] at this years ECCO Come by Booth [--] at Hall 2.2b (Level 2) and discover our unwavering commitment to pursuing scientific solutions for patients with pressing unmet needs. 💡 #ECCO2025" [X Link](https://x.com/Celltrioninc/status/1892828417776595049) 2025-02-21T06:47Z [---] followers, [---] engagements "Today we announced our full year and Q4 [----] earnings release. Read full report at: https://bit.ly/4dBPTLc https://bit.ly/4dBPTLc" [X Link](https://x.com/Celltrioninc/status/1894278176920277176) 2025-02-25T06:48Z [---] followers, [---] engagements "As global citizens we believe it is our responsibility to preserve the health and cleanliness of our planet. 🌍 At Celltrion we are dedicated to environmental sustainability and we continuously aim to minimizing our environmental impact and drive positive change for a better future. 🌱 Find out more at: #ESG #Environmental https://bit.ly/42irB6t https://bit.ly/42irB6t" [X Link](https://x.com/Celltrioninc/status/1894897855586017579) 2025-02-26T23:50Z [---] followers, [---] engagements "#Biosimilars positively impact not only individual patient access to treatment but also the healthcare system as a whole. Listen to our interview with Prof. Joo Manuel Braz Gonalves Full Professor in Faculty of Pharmacy at Universidade de Lisboa in which he discusses the impact of biosimilars on healthcare systems" [X Link](https://x.com/Celltrioninc/status/1899264570117742916) 2025-03-11T01:02Z [---] followers, [---] engagements "At Celltrion everything we do is driven by our strong sense of purpose. A purpose to help millions of patients have healthier lives. We also believe that the well-being of our employees and communities is just as important. From fostering an inclusive workplace to ensuring access to affordable medicines we're committed to building a healthier society. We are proud to make a meaningful impact both inside and outside our walls. 🤝❤ Find out more at: #ESG #Social http://bit.ly/42irB6t http://bit.ly/42irB6t" [X Link](https://x.com/Celltrioninc/status/1899970736355418160) 2025-03-12T23:48Z [---] followers, [---] engagements "Hear from Prof. Giorgio Walter Canonica Professor & Senior Consultant in Personalized Medicine Asthma & Allergy Clinic at Humanitas University & Research Hospital as he shares his thoughts on the way to increase the adoption of #biosimilars in the field of respiratory and allergy" [X Link](https://x.com/Celltrioninc/status/1902274416643584272) 2025-03-19T08:22Z [---] followers, [---] engagements "Through strong leadership and smart decision-making Celltrion is committed to exceeding boundaries and maintaining the highest standards for patients stakeholders and healthcare systems. Everyone at Celltrion approaches their work with ethics transparency and accountability. Our dedication purpose and determination will remain strong as we strive to create lasting value for a healthier future. 💪✨ Find out more at: #ESG #Governance http://bit.ly/42irB6t http://bit.ly/42irB6t" [X Link](https://x.com/Celltrioninc/status/1903960582929453554) 2025-03-24T00:02Z [---] followers, [---] engagements "Today we would like to spotlight Prof. Giorgio Walter Canonica and Prof. Alessandro Fiocchi distinguished Italian allergists and their discussion on the potential benefits of #biosimilars in improving patients access to treatment for allergic diseases. Tune in to find out more" [X Link](https://x.com/Celltrioninc/status/1904699480202764377) 2025-03-26T00:58Z [---] followers, [---] engagements "Welcome to the last edition of our #biosimilar video series. Wrapping up the discussion Prof. Joo Manuel Braz Gonalves Full Professor in Faculty of Pharmacy at Universidade de Lisboa shares his thoughts on the untapped opportunities in the biosimilars market that could shape the future and advance the treatment landscape" [X Link](https://x.com/Celltrioninc/status/1906513080114425875) 2025-03-31T01:05Z [---] followers, [---] engagements "How can we make the future more #sustainable From R&D to manufacturing and beyond Celltrion is continuously striving to drive positive change for our planet. 🌍 This #EarthDay discover how we're contributing to a healthier future through sustainable practices: #ESG http://bit.ly/42irB6t http://bit.ly/42irB6t" [X Link](https://x.com/Celltrioninc/status/1914473151909753136) 2025-04-22T00:15Z [---] followers, [---] engagements "Allergic diseases affect people of all ages genders and ethnicities. This Global CRSwNP Awareness Day Prof. Giorgio Walter Canonica from Humanitas University discusses the daily challenges faced by those with allergic asthma and #CRSwNP. Find more information on the Euforea website: https://www.euforea.eu/ https://www.euforea.eu/" [X Link](https://x.com/Celltrioninc/status/1915233343958102214) 2025-04-24T02:36Z [---] followers, [--] engagements "We're thrilled to welcome top gastroenterologists and rheumatologists from France to discuss the latest advancements in autoimmune disease treatments biosimilars and patient welfare Kicking off our new video series we have Prof. Anthony Buisson gastroenterologist at Clermont-Ferrand University Hospital explaining what a #biosimilar is" [X Link](https://x.com/Celltrioninc/status/1917014098870763987) 2025-04-29T00:32Z [---] followers, [---] engagements "Severe #asthma can impact people both physically and psychologically. Hear from Prof. Jens Schreiber MD Head of Clinics for Pneumonology at University Hospital Magdeburg discussing the physical and psychological challenges that people living with severe asthma face" [X Link](https://x.com/Celltrioninc/status/1919983778161999886) 2025-05-07T05:12Z [---] followers, [---] engagements "Today we announced our Q1 [----] earnings release. Read full report at: https://bit.ly/4dBPTLc https://bit.ly/4dBPTLc" [X Link](https://x.com/Celltrioninc/status/1920763811293794548) 2025-05-09T08:52Z [---] followers, [---] engagements "Ahead of this year's #WorldIBDDay we spotlight Prof. Mathurin Fumery gastroenterologist at Amiens-Picardie University Hospital who talks about the unmet needs of #IBD patients and how #biosimilars address these challenges. Tune in to find out more" [X Link](https://x.com/Celltrioninc/status/1923173441747755470) 2025-05-16T00:27Z [---] followers, [---] engagements "Safety and efficacy are key when selecting a treatment. Did you know that #biosimilars are regulatory-approved medicines and perform just as well as their reference products Hear from Prof. Anthony Buisson gastroenterologist from Clermont-Ferrand University Hospital sharing his insights on the safety and efficacy of biosimilars" [X Link](https://x.com/Celltrioninc/status/1926861377127211355) 2025-05-26T04:42Z [---] followers, [---] engagements "Join us at #EAACI [----] Visit Booth F30 to learn more about our commitment to allergy care and patient well-being. Lets talk science solutions and a better future for patients. Explore how our science is driving real impact for patients around the world. 🔬" [X Link](https://x.com/Celltrioninc/status/1933841153889116462) 2025-06-14T10:57Z [---] followers, [---] engagements "🌱 Our sustainability journey in Europe has officially begun With the release of our [----] Sustainability Report our European affiliates take a unified step forward under the European Sustainability Reporting Standards (ESRS) framework. This report highlights how we are shaping sustainability strategies around key material topics and reaffirms our commitment to strengthening these efforts for a healthier more sustainable future. 🌿 Stay tuned as each affiliate gradually publishes its individual report on their official website. Read the full report: #ESG https://bit.ly/4kXoN4U" [X Link](https://x.com/Celltrioninc/status/1936934265020977482) 2025-06-22T23:48Z [---] followers, [---] engagements "#Biosimilars submit to strict clinical trials to prove their safety and efficacy. Listen to our interview with Prof. Jrme Avouac rheumatologist at Cochin University Hospital Paris as he explains the key elements that ensure the quality of biosimilars" [X Link](https://x.com/Celltrioninc/status/1937676050307383543) 2025-06-25T00:55Z [---] followers, [--] engagements "Every day individuals worldwide are diagnosed with conditions that require biological therapy. The availability of #biosimilars has significantly facilitated access to essential biologic treatments for patients. Professor Anthony Buisson a gastroenterologist at Clermont-Ferrant University Hospital discusses the critical role biosimilars play in enhancing patient care" [X Link](https://x.com/Celltrioninc/status/1944915543292805230) 2025-07-15T00:22Z [---] followers, [---] engagements "In most cases comprehensive data is required to prove the biosimilarity between #biosimilars and reference products. Hear from Prof. Jrme Avouac a rheumatologist at Cochin University Hospital Paris as he discusses how the safety and effectiveness of biosimilars are ensured" [X Link](https://x.com/Celltrioninc/status/1955450638529384790) 2025-08-13T02:05Z [---] followers, [--] engagements "Ensuring the long-term sustainability of medications is crucial particularly for patients with chronic diseases as these conditions have lifelong impacts. In this video Professor Mathurin Fumery a gastroenterologist at Amiens-Picardie University Hospital explains how #biosimilars can improve long-term access to treatment for patients while alleviating the burden on the healthcare system" [X Link](https://x.com/Celltrioninc/status/1962675801763303542) 2025-09-02T00:35Z [---] followers, [---] engagements "Greetings from Amsterdam #ERSCongress [----] began on Saturday. Come by booth C.03 meet our team see our innovations in #respiratory and learn how we aim to improve patient outcomes with science-driven solutions. 🌍🩺" [X Link](https://x.com/anyuser/status/1972571790598946839) 2025-09-29T07:58Z [---] followers, [---] engagements "With the growing importance of #ESG in the bio industry Celltrion Inc. started full-scale activities to strengthen its ESG strategies. We are proud to support this initiative to care for our planet. 🌏 #Sustainability #Environment #SocialImpact" [X Link](https://x.com/Celltrioninc/status/1565587102582321153) 2022-09-02T06:27Z [---] followers, [--] engagements "BREAKING NEWS: Today Celltrion Healthcare has merged with Celltrion Inc. to enhance its market position and create opportunities for growth. As of today we will deliver up-to-date and unified news in the social space under the name of Celltrion. Stay tuned #DaringtoGoBeyond" [X Link](https://x.com/Celltrioninc/status/1740975069206327592) 2023-12-30T05:56Z [---] followers, [---] engagements "BREAKING NEWS: We are delighted to announce that the @EMA_News #CHMP has adopted a positive opinion recommending the approval of three #biosimilars from Celltrion. This will bring us one step closer to offering the patient-centric treatment for people living with various diseases in Europe. View press release https://bit.ly/3VF4DlG https://bit.ly/3VF4DlG" [X Link](https://x.com/Celltrioninc/status/1868446338012320163) 2024-12-16T00:01Z [---] followers, [---] engagements "Today is #WorldCancerDay. We stand united in the fight against cancer focusing on people-centered care and seeking new ways to make a meaningful impact. Together with the help of advances in #biosimilars we aim to improve access to life-saving treatments for patients worldwide. 🌎 Watch full video at: #UnitedbyUnique https://bit.ly/4gou9mP What exactly is a #biosimilar and how could it expand #cancer treatment options for patients Explore the science behind these therapies in the #RewritingCancer series from @BBCStoryWorks @UICC supported by Celltrion Inc. https://t.co/idB0ev8qJP" [X Link](https://x.com/Celltrioninc/status/1886583259053875308) 2025-02-04T01:11Z [---] followers, [---] engagements "We are heading to our first on-site congress of the year #ECCO2025 Join us in Berlin to learn more about our recent advancements in #IBD care. 📅 Wednesday February [--] Saturday February [--] 📍 Booth [--] Hall 2.2b (Level 2) Messe Berlin" [X Link](https://x.com/Celltrioninc/status/1888820222808994051) 2025-02-10T05:20Z [---] followers, [---] engagements "If you are attending #ECCO2025 dont miss our Meet The Expert session where we will discuss the latest clinical data on treatment in #IBD. Find them at Celltrion booth (Hall 2.2) 📌 Meet Prof. Stefan Schreiber and Dr. Julia Husman on Friday [--] February 15:10-15:40 CET 📌 Meet Prof. Anthony Buisson on Saturday [--] February 10:20-10:50 CET #MeetTheExperts" [X Link](https://x.com/Celltrioninc/status/1890203948449165754) 2025-02-14T00:58Z [---] followers, [---] engagements "Today at #ECCO2025 we presented our latest data which includes multiple post hoc analyses from the LIBERTY study. These insights underscore our commitment to improving patient outcomes through breakthrough #IBD research. View the press release here: https://bit.ly/3Qrhuov https://bit.ly/3Qrhuov" [X Link](https://x.com/Celltrioninc/status/1892726332066263489) 2025-02-21T00:01Z [---] followers, [---] engagements "BREAKING NEWS: We are delighted to announce that the @EU_Commission has approved Celltrions treatment for #rheumatic diseases. This represents a significant advancement in our commitment to people living with autoimmune diseases in Europe. View press release here: https://bit.ly/4kqOPOv https://bit.ly/4kqOPOv" [X Link](https://x.com/Celltrioninc/status/1893815617595318417) 2025-02-24T00:10Z [---] followers, [---] engagements "Celltrion will be attending #EULAR2025 in Barcelona. We will proudly be showcasing our ongoing commitment to advancing scientific progress in addressing the unmet needs of people living with rheumatic diseases. 📅 Wednesday June [--] Saturday June [--] 📍 Booth C5 Hall [--] Fira de Barcelona" [X Link](https://x.com/Celltrioninc/status/1928259340387111427) 2025-05-30T01:17Z [---] followers, [---] engagements "📢 Were excited to announce that Celltrion will join the IBD Practice on Air [----] a webinar series on Inflammatory Bowel Disease (#IBD). Find the details of our symposium session below and dont forget to register 📅 Date: Thursday 5th June Time: 18:45 19:15 CEST (30 min) 🎙 Title: What is new in SC Infliximab 👩⚕ Speaker: Dr. Angela Variola Click to register: https://bit.ly/4muzfCs https://bit.ly/4muzfCs" [X Link](https://x.com/Celltrioninc/status/1930187627581599856) 2025-06-04T08:59Z [---] followers, [---] engagements "Celltrion is heading to the [----] #EAACI Congress Join us as we share our latest efforts in allergy care and reaffirm our commitment to patients worldwide. 📅 When Friday June [--] Monday June [--] 📍 Where Hall [--] Booth F30 Scottish Event Campus (SEC) Glasgow" [X Link](https://x.com/Celltrioninc/status/1931863935545938113) 2025-06-09T00:00Z [---] followers, [---] engagements "Heading to #EULAR2025 Make sure to visit Celltrions booth and explore our latest advances in treating rheumatic diseases 💊🧬 Meet our colleagues learn about our work in immunology and see how were hoping to drive better outcomes for patients worldwide" [X Link](https://x.com/Celltrioninc/status/1933063025629560838) 2025-06-12T07:25Z [---] followers, [---] engagements "Celltrion has released its 2024/25 Sustainability Report 🌍 Discover our continued commitment to sustainability ethical governance and social responsibility. We believe in long-term value through transparency. Together we can build a healthier and more environmentally friendly future. 📎 https://bit.ly/3G9QgkY https://bit.ly/3G9QgkY" [X Link](https://x.com/Celltrioninc/status/1938411765244874807) 2025-06-27T01:39Z [---] followers, [---] engagements "We announced our Q2 [----] earnings release on [--] August. Read full report at: https://bit.ly/4mdkuDy https://bit.ly/4mdkuDy" [X Link](https://x.com/Celltrioninc/status/1953247674318373272) 2025-08-07T00:11Z [---] followers, [---] engagements "Celltrion is proud to make its debut at #EURETINA2025 one of the most influential gatherings in #ophthalmology. 📍 Visit us at Booth 2.D15 & 2.D20 from September [--] at Le Palais des Congrs and join us as we explore innovative solutions in ophthalmology and connect with global retinal specialists. 🔬👁" [X Link](https://x.com/Celltrioninc/status/1960231353435459642) 2025-08-26T06:42Z [---] followers, [---] engagements "Celltrion is stepping into the European eye care scene for the first time. 👁 Join us at our booth to explore our latest innovations in eye care. 💡🔬 Meet our team discover how were expanding in #ophthalmology and see whats next for patient-focused therapies. Come and visit us on the exhibition floor #EURETINA2025" [X Link](https://x.com/Celltrioninc/status/1963753391420797197) 2025-09-04T23:57Z [---] followers, [---] engagements "Celltrion is excited to participate in #EADV Congress [----] Join us at the Paris Convention Centre from September [----] and visit booth F04 to explore our latest dermatological innovations and how we're advancing patient care across Europe. ✨🔍" [X Link](https://x.com/Celltrioninc/status/1965702700244566493) 2025-09-10T09:03Z [---] followers, [---] engagements "Celltrion is proud to join the global respiratory community at #ERSCongress [----] Visit us at booth C.03 in RAI Amsterdam Hall [--] and discover our latest advances in treatments supporting #respiratory care. 🔬" [X Link](https://x.com/anyuser/status/1968172758594105666) 2025-09-17T04:38Z [---] followers, [---] engagements "Were excited to present our latest research at this years #EADV Congress. The clinical outcomes of our products reflect our ongoing dedication to improving the lives of individuals affected by dermatological conditions. Read more https://bit.ly/3VpfD6s https://bit.ly/3VpfD6s" [X Link](https://x.com/anyuser/status/1968904813472542845) 2025-09-19T05:07Z [---] followers, [---] engagements "Were excited to join CPHI Europe [----] Join us at Booth 6.1C70 to meet the Celltrion team and discover how were shaping the future of biopharmaceuticals.💡 #Celltrion #CPHI" [X Link](https://x.com/Celltrioninc/status/1980425138396098634) 2025-10-21T00:05Z [---] followers, [--] engagements "Were excited to join CPHI Europe [----] Join us at Booth 6.1C70 to meet the Celltrion team and discover how were shaping the future of biopharmaceuticals.💡 #Celltrion #CPHI" [X Link](https://x.com/Celltrioninc/status/1980447882961645997) 2025-10-21T01:35Z [---] followers, [--] engagements "We were honored to welcome global #IBD leaders to Celltrions headquarters where they toured our state-of-the-art facilities and shared valuable insights on advancing scientific innovation and enhancing patient care worldwide. During the visit participants experienced Celltrions commitment to innovation and patient centered care exchanging perspectives on how we can continue driving progress in global healthcare together. It was a truly inspiring opportunityto connect collaborate and reaffirm our shared goal of improving access totreatment for patients worldwide. A heartfelt thank you to" [X Link](https://x.com/Celltrioninc/status/1988054173502627917) 2025-11-11T01:20Z [---] followers, [--] engagements "BREAKING NEWS: Were excited to share that the European Commission has granted the label extension for an additional presentation of our #omalizumab #biosimilar. This milestone represents a meaningful contribution to reducing the burden of disease and improving patients quality of life. We will continue our efforts to increase accessibility for patients. - View press release here: https://bit.ly/3LKngmo https://bit.ly/3LKngmo" [X Link](https://x.com/anyuser/status/1990643631871738366) 2025-11-18T04:50Z [---] followers, [---] engagements "BREAKING NEWS: Were proud to share that the European Commission has authorized the worlds first liquid formulation of IV #infliximab This milestone marks an important step forward in reducing the workload of healthcare professionals and enhancing hospital operational efficiency - enabling more focus on patient care. - View press release here: https://shorturl" [X Link](https://x.com/Celltrioninc/status/1990702061298545085) 2025-11-18T08:42Z [---] followers, [--] engagements "BREAKING NEWS: Were proud to share that the European Commission has authorized the worlds first liquid formulation of IV #infliximab This milestone marks an important step forward in reducing the workload of healthcare professionals and enhancing hospital operational efficiency - enabling more focus on patient care. - View press release here: https://shorturl.at/45isq https://shorturl.at/45isq" [X Link](https://x.com/anyuser/status/1991404843198758913) 2025-11-20T07:14Z [---] followers, [---] engagements "Since their introduction #biosimilars have progressively transformed patient perceptions. Prof. Jrme Avouac rheumatologist at Cochin University Hospital Paris describes how biosimilars have gained patients trust throughout the years" [X Link](https://x.com/anyuser/status/1995644083549643009) 2025-12-02T00:00Z [---] followers, [--] engagements "BREAKING NEWS: Were proud to announce that the CHMP has adopted a positive opinion and recommended marketing authorization for autoinjector (pre-filled pen) of our #ustekinumab #biosimilar. This marks an important milestone in offering patients both convenience and practical usability while expanding available treatment options. Find more https://bit.ly/44UOHAH https://bit.ly/44UOHAH" [X Link](https://x.com/anyuser/status/2001517517018407089) 2025-12-18T04:58Z [---] followers, [---] engagements "Celltrion is thrilled to participate in #UEGWeek [----] the premier event in European #gastroenterology From October [--] at Messe Berlin visit booth number [----] to explore our robust #IBD solutions. 🌍🔍 Talk with our experts dive into detailed insights and discover how Celltrion is redefining personalized care for digestive diseases. https://twitter.com/i/web/status/1971385401018610164 https://twitter.com/i/web/status/1971385401018610164" [X Link](https://x.com/anyuser/status/1971385401018610164) 2025-09-26T01:24Z [---] followers, [---] engagements "Celltrion is now participating in UEGW [----] Discover our latest data and insights in the field of gastroenterology by visiting our booth. We look forward to meeting you in person at the congress. Stop by and be part of the conversation shaping the future of gastroenterology. #UEGW2025 #Celltrion #BuiltonTrustDrivingInnovation #Gastroenterology https://twitter.com/i/web/status/1974812274964803896 https://twitter.com/i/web/status/1974812274964803896" [X Link](https://x.com/anyuser/status/1974812274964803896) 2025-10-05T12:21Z [---] followers, [---] engagements "At UEG Week [----] Celltrion presented real-world data on subcutaneous infliximab during a Meet-the-Expert session. Celltrion remains committed to advancing innovative biologics improving access and supporting sustainable healthcare worldwide. View the press release here: http://bit.ly/46VKRr4 http://bit.ly/46VKRr4" [X Link](https://x.com/anyuser/status/1975145585310306480) 2025-10-06T10:26Z [---] followers, [---] engagements "Were proud to announce that Celltrion has been selected as a finalist for the [----] Global Generics & Biosimilars Awards This recognition in the Biosimilar Initiative of the Year category highlights Celltrions leadership in advancing access to high-quality biologics through innovation reliability and sustainable growth. By achieving major regulatory milestones and expanding into new therapeutic areas Celltrion continues to set new standards for excellence in the global biosimilar industry. We remain dedicated to improving treatment access and patient outcomes worldwide through our fully" [X Link](https://x.com/anyuser/status/1978005586676707727) 2025-10-14T07:50Z [---] followers, [---] engagements "Were excited to join CPHI Frankfurt [----] Join us at Booth 6.1C70 to meet the Celltrion team and discover how were shaping the future of biopharmaceuticals.💡 #Celltrion #CPHI" [X Link](https://x.com/Celltrioninc/status/1980800509822066874) 2025-10-22T00:56Z [---] followers, [---] engagements "We announced our Q3 [----] earnings release on [--] November. Read the full report here: https://bit.ly/4hKWfuR https://bit.ly/4hKWfuR" [X Link](https://x.com/anyuser/status/1986300607549088210) 2025-11-06T05:12Z [---] followers, [--] engagements "We were honored to welcome global #IBD leaders to Celltrions headquarters where they toured our state-of-the-art facilities and shared valuable insights on advancing scientific innovation and enhancing patient care worldwide. During the visit participants experienced Celltrions commitment to innovation and patient centered care exchanging perspectives on how we can continue driving progress in global healthcare together. It was a truly inspiring opportunityto connect collaborate and reaffirm our shared goal of improving access totreatment for patients worldwide. A heartfelt thank you to" [X Link](https://x.com/anyuser/status/1988133221763359050) 2025-11-11T06:34Z [---] followers, [--] engagements "Celltrion presented its key strategic priorities and updates on its innovative drug pipeline and therapies alongside its U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference. At the conference the company outlined its strategic direction toward innovative therapeutics building on its deep antibody expertise. This includes plans across antibody-drug conjugates (ADCs) multispecific antibodies (MsAbs). In addition Celltrion presented its strategy to scale U.S. manufacturing and R&D capabilities as part of its long-term growth plan reinforcing supply" [X Link](https://x.com/anyuser/status/2011311573156179989) 2026-01-14T05:37Z [---] followers, [--] engagements "We announced our FY2025 / 4Q [----] earnings release on [--] February. Read the full report here: https://bit.ly/4hKWfuR https://bit.ly/4hKWfuR" [X Link](https://x.com/anyuser/status/2019219879405216204) 2026-02-05T01:21Z [---] followers, [--] engagements "Celltrion is pleased to participate in ECCO Congress [----]. We are honored to take part in this meaningful global congress dedicated to Crohns disease and ulcerative colitis where experts come together to advance discussions in the field of inflammatory bowel disease (IBD). During the congress we invite you to visit Celltrion at Booth #22 and connect with our team. 📌Booth #22 #ECCO #ECCO2026 #ECCOCongress https://twitter.com/i/web/status/2021763950602596431 https://twitter.com/i/web/status/2021763950602596431" [X Link](https://x.com/anyuser/status/2021763950602596431) 2026-02-12T01:51Z [---] followers, [--] engagements "Celltrion is pleased to participate in ECCO Congress [----]. We are honored to take part in this meaningful global congress dedicated to Crohns disease and ulcerative colitis where experts come together to advance discussions in the field of inflammatory bowel disease (IBD). During the congress we invite you to visit Celltrion at Booth #22 and connect with our team. 📌Booth #22 #ECCO #ECCO2026 #ECCOCongress https://twitter.com/i/web/status/2021763950602596431 https://twitter.com/i/web/status/2021763950602596431" [X Link](https://x.com/anyuser/status/2021763950602596431) 2026-02-12T01:51Z [---] followers, [--] engagements "We announced our FY2025 / 4Q [----] earnings release on [--] February. Read the full report here: https://bit.ly/4hKWfuR https://bit.ly/4hKWfuR" [X Link](https://x.com/anyuser/status/2019219879405216204) 2026-02-05T01:21Z [---] followers, [--] engagements "Welcome to the last edition of our #biosimilar video series. Wrapping up the discussion Prof. Anthony Buisson gastroenterologist at Clermont-FerrantUniversity Hospital shares his thoughts on the evolving patient acceptance and perception of biosimilars over the years" [X Link](https://x.com/anyuser/status/2015984573575020627) 2026-01-27T03:05Z [---] followers, [--] engagements "Celltrion presented its key strategic priorities and updates on its innovative drug pipeline and therapies alongside its U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference. At the conference the company outlined its strategic direction toward innovative therapeutics building on its deep antibody expertise. This includes plans across antibody-drug conjugates (ADCs) multispecific antibodies (MsAbs). In addition Celltrion presented its strategy to scale U.S. manufacturing and R&D capabilities as part of its long-term growth plan reinforcing supply" [X Link](https://x.com/anyuser/status/2011311573156179989) 2026-01-14T05:37Z [---] followers, [--] engagements "BREAKING NEWS: Were proud to announce that the CHMP has adopted a positive opinion and recommended marketing authorization for autoinjector (pre-filled pen) of our #ustekinumab #biosimilar. This marks an important milestone in offering patients both convenience and practical usability while expanding available treatment options. Find more https://bit.ly/44UOHAH https://bit.ly/44UOHAH" [X Link](https://x.com/anyuser/status/2001517517018407089) 2025-12-18T04:58Z [---] followers, [---] engagements "Since their introduction #biosimilars have progressively transformed patient perceptions. Prof. Jrme Avouac rheumatologist at Cochin University Hospital Paris describes how biosimilars have gained patients trust throughout the years" [X Link](https://x.com/anyuser/status/1995644083549643009) 2025-12-02T00:00Z [---] followers, [--] engagements "BREAKING NEWS: Were proud to share that the European Commission has authorized the worlds first liquid formulation of IV #infliximab This milestone marks an important step forward in reducing the workload of healthcare professionals and enhancing hospital operational efficiency - enabling more focus on patient care. - View press release here: https://shorturl.at/45isq https://shorturl.at/45isq" [X Link](https://x.com/anyuser/status/1991404843198758913) 2025-11-20T07:14Z [---] followers, [---] engagements "BREAKING NEWS: Were excited to share that the European Commission has granted the label extension for an additional presentation of our #omalizumab #biosimilar. This milestone represents a meaningful contribution to reducing the burden of disease and improving patients quality of life. We will continue our efforts to increase accessibility for patients. - View press release here: https://bit.ly/3LKngmo https://bit.ly/3LKngmo" [X Link](https://x.com/anyuser/status/1990643631871738366) 2025-11-18T04:50Z [---] followers, [---] engagements "We were honored to welcome global #IBD leaders to Celltrions headquarters where they toured our state-of-the-art facilities and shared valuable insights on advancing scientific innovation and enhancing patient care worldwide. During the visit participants experienced Celltrions commitment to innovation and patient centered care exchanging perspectives on how we can continue driving progress in global healthcare together. It was a truly inspiring opportunityto connect collaborate and reaffirm our shared goal of improving access totreatment for patients worldwide. A heartfelt thank you to" [X Link](https://x.com/anyuser/status/1988133221763359050) 2025-11-11T06:34Z [---] followers, [--] engagements "We announced our Q3 [----] earnings release on [--] November. Read the full report here: https://bit.ly/4hKWfuR https://bit.ly/4hKWfuR" [X Link](https://x.com/anyuser/status/1986300607549088210) 2025-11-06T05:12Z [---] followers, [--] engagements "Were excited to join CPHI Frankfurt [----] Join us at Booth 6.1C70 to meet the Celltrion team and discover how were shaping the future of biopharmaceuticals.💡 #Celltrion #CPHI" [X Link](https://x.com/Celltrioninc/status/1980800509822066874) 2025-10-22T00:56Z [---] followers, [---] engagements "Were proud to announce that Celltrion has been selected as a finalist for the [----] Global Generics & Biosimilars Awards This recognition in the Biosimilar Initiative of the Year category highlights Celltrions leadership in advancing access to high-quality biologics through innovation reliability and sustainable growth. By achieving major regulatory milestones and expanding into new therapeutic areas Celltrion continues to set new standards for excellence in the global biosimilar industry. We remain dedicated to improving treatment access and patient outcomes worldwide through our fully" [X Link](https://x.com/anyuser/status/1978005586676707727) 2025-10-14T07:50Z [---] followers, [---] engagements "At UEG Week [----] Celltrion presented real-world data on subcutaneous infliximab during a Meet-the-Expert session. Celltrion remains committed to advancing innovative biologics improving access and supporting sustainable healthcare worldwide. View the press release here: http://bit.ly/46VKRr4 http://bit.ly/46VKRr4" [X Link](https://x.com/anyuser/status/1975145585310306480) 2025-10-06T10:26Z [---] followers, [---] engagements "Celltrion is now participating in UEGW [----] Discover our latest data and insights in the field of gastroenterology by visiting our booth. We look forward to meeting you in person at the congress. Stop by and be part of the conversation shaping the future of gastroenterology. #UEGW2025 #Celltrion #BuiltonTrustDrivingInnovation #Gastroenterology https://twitter.com/i/web/status/1974812274964803896 https://twitter.com/i/web/status/1974812274964803896" [X Link](https://x.com/anyuser/status/1974812274964803896) 2025-10-05T12:21Z [---] followers, [---] engagements "Greetings from Amsterdam #ERSCongress [----] began on Saturday. Come by booth C.03 meet our team see our innovations in #respiratory and learn how we aim to improve patient outcomes with science-driven solutions. 🌍🩺" [X Link](https://x.com/anyuser/status/1972571790598946839) 2025-09-29T07:58Z [---] followers, [---] engagements "Celltrion is thrilled to participate in #UEGWeek [----] the premier event in European #gastroenterology From October [--] at Messe Berlin visit booth number [----] to explore our robust #IBD solutions. 🌍🔍 Talk with our experts dive into detailed insights and discover how Celltrion is redefining personalized care for digestive diseases. https://twitter.com/i/web/status/1971385401018610164 https://twitter.com/i/web/status/1971385401018610164" [X Link](https://x.com/anyuser/status/1971385401018610164) 2025-09-26T01:24Z [---] followers, [---] engagements "Were excited to present our latest research at this years #EADV Congress. The clinical outcomes of our products reflect our ongoing dedication to improving the lives of individuals affected by dermatological conditions. Read more https://bit.ly/3VpfD6s https://bit.ly/3VpfD6s" [X Link](https://x.com/anyuser/status/1968904813472542845) 2025-09-19T05:07Z [---] followers, [---] engagements "#EADV [----] has kicked off in Paris Drop by booth F04 at the Paris Convention Centre to immerse yourself in our latest skin care solutions and clinical breakthroughs. 💡🧴 Connect with our experts explore our contributions to dermatological medicine and discover how we're helping shape the future of skin health" [X Link](https://x.com/anyuser/status/1968553270810726891) 2025-09-18T05:50Z [---] followers, [---] engagements "Celltrion is proud to join the global respiratory community at #ERSCongress [----] Visit us at booth C.03 in RAI Amsterdam Hall [--] and discover our latest advances in treatments supporting #respiratory care. 🔬" [X Link](https://x.com/anyuser/status/1968172758594105666) 2025-09-17T04:38Z [---] followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@Celltrioninc Celltrion
Celltrion posts on X about breaking news, release, global, $068270ks the most. They currently have [---] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours.
Engagements: undefined #
- [--] Week [--] +48%
- [--] Month [---] +51%
- [--] Months [-----] +14%
- [--] Year [-----] -77%
Mentions: undefined #
- [--] Months [--] -11%
- [--] Year [--] +173%
Followers: [---] #
- [--] Week [---] -0.26%
- [--] Month [---] +1%
- [--] Months [---] +4.30%
- [--] Year [---] +20%
CreatorRank: undefined #
Social Influence
Social category influence travel destinations countries finance stocks financial services
Social topic influence breaking news, release, global, $068270ks, paris, future, breaking, in the, amsterdam, share
Top accounts mentioned or mentioned by @bbcstoryworks @eucommission @emanews @uicc
Top Social Posts
Top posts by engagements in the last [--] hours
"#NationalWomensEqualityDay marks a turning point in the history of the struggle for equal treatment of women and womens rights. We'd like to celebrate this day introducing our female leaders who accelerate their careers with great accomplishments. #BreakingTheBoundaries"
X Link 2023-08-24T09:18Z [---] followers, [---] engagements
"We are excited to share that we will be participating in #PANLAR2024 Annual Congress this week in Barranquilla Colombia We will be discussing our work to address the unmet needs for patients living with rheumatic disease in Latin America. #Rheumatology"
X Link 2024-04-09T08:17Z [---] followers, [--] engagements
"BREAKING NEWS: We are thrilled to announce the EC approval of the first and only #omalizumab #biosimilar approved in Europe that will help to increase access to needed medicines. This milestone shines a light on the importance of biosimilars and our commitment to providing patient-centric approaches to care for allergic diseases in Europe. Find out more at: https://shorturl.at/YLIvh https://shorturl.at/YLIvh"
X Link 2024-05-24T04:15Z [---] followers, [--] engagements
"Embark on a #WheresCC journey to Hungary & Poland 🌍✈ Uncover the hurdles faced by IBD patients due to strict diagnostic criteria. Let's unite for accessible care 🤝 Spot CC and join the cause at 💡 #IBDHasNoBorders http://www.WhereisCC.com http://www.WhereisCC.com"
X Link 2024-06-04T06:31Z [---] followers, 32.9K engagements
"BREAKING NEWS: We are pleased to announce the EC approval of an #ustekinumab #biosimilar. This approval represents a significant milestone as we aim to lead the way in providing patient-centric care for autoimmune diseases. View press release here: https://shorturl.at/Y3mTF https://shorturl.at/Y3mTF"
X Link 2024-08-25T23:49Z [---] followers, [---] engagements
"Celltrion will be attending the Morgan Stanley 22nd Annual Global Healthcare Conference in New York. #Savethedate as our Chairman and CEO will be presenting at a fireside chat on Friday September [--]. Learn more at: https://shorturl.at/X9KcB https://shorturl.at/X9KcB"
X Link 2024-08-28T00:16Z [---] followers, [---] engagements
"Following the European Commissions approval of #ustekinumab #biosimilar in Europe Taehun Ha Senior Vice President and Head of Europe Division at Celltrion shares the significance of this milestone for patients with multiple chronic inflammatory diseases"
X Link 2024-08-29T01:37Z [---] followers, [---] engagements
"Celltrion is heading to #ERSCongress2024 Join us in Vienna to hear about our advancements in #respiratory disease care. 📅 When Saturday September [--] Wednesday September [--] 📍 Where Booth C4 Exhibition Hall B RX Messe Wien"
X Link 2024-08-30T00:41Z [---] followers, [---] engagements
"We are excited to be attending #WAC2024 this week. Join us in Lisbon where well share more on our progress in advancing care for people living with allergic diseases. 📅 Friday September [--] Sunday September [--] 📍 Exhibition Hall Estoril Congress Center"
X Link 2024-09-24T04:23Z [---] followers, [---] engagements
"Celltrion will be at #UEGWeek [----] #SaveTheDate and connect with us. See you in Vienna 📅 When Saturday October [--] Tuesday October [--] 📍 Where Booth [--] Hall B Messe Wien Vienna Austria #Gastroenterology #crohnsdisease #ulcerativecolitis"
X Link 2024-10-02T08:50Z [---] followers, [--] engagements
"In our #RewritingCancer video produced by @BBCStoryWorks we delve into the experiences of Emma Foreman Consultant Pharmacist at The Royal Marsden and Jung Jin Seo Chairman Celltrion. Learn how #biosimilars could help more patients access the treatments they need and rewrite the outcomes of cancer"
X Link 2024-10-03T23:37Z [---] followers, [---] engagements
"Join us on site at this years #UEGWeek Meet The Expert session at Celltrion booth (Hall B). 📌 Meet Prof. Dr. Stefan Schreiber on Sunday [--] October 13:00-13:30 CEST 📌 Meet Dr. Angela Variola on Monday [--] October 14:00-14:30 CEST #UEGW2024 #MeetTheExperts"
X Link 2024-10-08T08:19Z [---] followers, [---] engagements
"Greetings from Vienna #UEGWeek [----] began on Saturday Make sure to stop by booth [--] and learn more about our work in #gastroenterology and our goal to address the unmet needs of GI patients. 😊"
X Link 2024-10-14T06:36Z [---] followers, [---] engagements
"Today we announced our Q3 [----] earnings release. Read full report https://bit.ly/4dBPTLc https://bit.ly/4dBPTLc"
X Link 2024-11-08T09:18Z [---] followers, [--] engagements
"Today we announce the successful acquisition of iQone Healthcare Switzerland a specialty pharmaceutical company focused on sales marketing and distribution in Switzerland. This strategic acquisition will further solidify our market presence and portfolio expediting our direct sales capabilities. For more details please view the press release here: http://bit.ly/4hRheeW http://bit.ly/4hRheeW"
X Link 2024-11-15T00:41Z [---] followers, [--] engagements
"We're excited to launch a new video featuring distinguished physicians around the world. In this video Prof. Jens Schreiber MD Head of Clinics for Pneumonology at University Hospital Magdeburg explains what a #biosimilar is"
X Link 2024-12-03T01:49Z [---] followers, [--] engagements
"#Biosimilars undergo a rigorous process to be approved by regulatory authorities. During the process extrapolation plays a very important role in providing the data needed to prove the quality of the drug. Hear from Prof. Joo Manuel Braz Gonalves Full Professor in Faculty of Pharmacy at Universidade de Lisboa about the importance of extrapolation in regulatory approval of biosimilars"
X Link 2024-12-13T00:37Z [---] followers, [--] engagements
"📢 Celltrion will be attending the J.P. Morgan 43rd Annual Healthcare Conference in San Francisco California. #Savethedate as our Chairman and CEO will be presenting at the main track on Tuesday [--] January. 📅 Tuesday January [--] at 5:15 p.m. PST 📍 Grand Ballroom The Westin St. Francis San Francisco California #DaringToGoBeyond"
X Link 2025-01-13T03:00Z [---] followers, [---] engagements
"🌟 Transforming the Future of Crohns Disease 🌟 Celltrion is proud to join the #INTERCEPT_IHI project Europes first-ever trial using innovative #biomarkers to prevent the onset of #CrohnsDisease as a partner. 🎉 📍 Save the date for the official kick-off in Berlin Germany on 19th February [----] #MedicalInnovation #PreventCrohns #FutureOfHealth #HealthcareLeadership"
X Link 2025-01-22T09:03Z [---] followers, [---] engagements
"BREAKING NEWS: We are thrilled to announce that the @EU_Commission granted marketing authorization for our two #biosimilars in the European market. This announcement further expands Celltrions diverse biosimilar portfolio. We are committed to providing patient-centric care across multiple therapeutic areas in Europe. View the press release here: https://bit.ly/3QlLpyF https://bit.ly/3QlLpyF"
X Link 2025-02-19T04:44Z [---] followers, [--] engagements
"We are excited to launch our first on-site congress activity of [----] at this years ECCO Come by Booth [--] at Hall 2.2b (Level 2) and discover our unwavering commitment to pursuing scientific solutions for patients with pressing unmet needs. 💡 #ECCO2025"
X Link 2025-02-21T06:47Z [---] followers, [---] engagements
"Today we announced our full year and Q4 [----] earnings release. Read full report at: https://bit.ly/4dBPTLc https://bit.ly/4dBPTLc"
X Link 2025-02-25T06:48Z [---] followers, [---] engagements
"As global citizens we believe it is our responsibility to preserve the health and cleanliness of our planet. 🌍 At Celltrion we are dedicated to environmental sustainability and we continuously aim to minimizing our environmental impact and drive positive change for a better future. 🌱 Find out more at: #ESG #Environmental https://bit.ly/42irB6t https://bit.ly/42irB6t"
X Link 2025-02-26T23:50Z [---] followers, [---] engagements
"#Biosimilars positively impact not only individual patient access to treatment but also the healthcare system as a whole. Listen to our interview with Prof. Joo Manuel Braz Gonalves Full Professor in Faculty of Pharmacy at Universidade de Lisboa in which he discusses the impact of biosimilars on healthcare systems"
X Link 2025-03-11T01:02Z [---] followers, [---] engagements
"At Celltrion everything we do is driven by our strong sense of purpose. A purpose to help millions of patients have healthier lives. We also believe that the well-being of our employees and communities is just as important. From fostering an inclusive workplace to ensuring access to affordable medicines we're committed to building a healthier society. We are proud to make a meaningful impact both inside and outside our walls. 🤝❤ Find out more at: #ESG #Social http://bit.ly/42irB6t http://bit.ly/42irB6t"
X Link 2025-03-12T23:48Z [---] followers, [---] engagements
"Hear from Prof. Giorgio Walter Canonica Professor & Senior Consultant in Personalized Medicine Asthma & Allergy Clinic at Humanitas University & Research Hospital as he shares his thoughts on the way to increase the adoption of #biosimilars in the field of respiratory and allergy"
X Link 2025-03-19T08:22Z [---] followers, [---] engagements
"Through strong leadership and smart decision-making Celltrion is committed to exceeding boundaries and maintaining the highest standards for patients stakeholders and healthcare systems. Everyone at Celltrion approaches their work with ethics transparency and accountability. Our dedication purpose and determination will remain strong as we strive to create lasting value for a healthier future. 💪✨ Find out more at: #ESG #Governance http://bit.ly/42irB6t http://bit.ly/42irB6t"
X Link 2025-03-24T00:02Z [---] followers, [---] engagements
"Today we would like to spotlight Prof. Giorgio Walter Canonica and Prof. Alessandro Fiocchi distinguished Italian allergists and their discussion on the potential benefits of #biosimilars in improving patients access to treatment for allergic diseases. Tune in to find out more"
X Link 2025-03-26T00:58Z [---] followers, [---] engagements
"Welcome to the last edition of our #biosimilar video series. Wrapping up the discussion Prof. Joo Manuel Braz Gonalves Full Professor in Faculty of Pharmacy at Universidade de Lisboa shares his thoughts on the untapped opportunities in the biosimilars market that could shape the future and advance the treatment landscape"
X Link 2025-03-31T01:05Z [---] followers, [---] engagements
"How can we make the future more #sustainable From R&D to manufacturing and beyond Celltrion is continuously striving to drive positive change for our planet. 🌍 This #EarthDay discover how we're contributing to a healthier future through sustainable practices: #ESG http://bit.ly/42irB6t http://bit.ly/42irB6t"
X Link 2025-04-22T00:15Z [---] followers, [---] engagements
"Allergic diseases affect people of all ages genders and ethnicities. This Global CRSwNP Awareness Day Prof. Giorgio Walter Canonica from Humanitas University discusses the daily challenges faced by those with allergic asthma and #CRSwNP. Find more information on the Euforea website: https://www.euforea.eu/ https://www.euforea.eu/"
X Link 2025-04-24T02:36Z [---] followers, [--] engagements
"We're thrilled to welcome top gastroenterologists and rheumatologists from France to discuss the latest advancements in autoimmune disease treatments biosimilars and patient welfare Kicking off our new video series we have Prof. Anthony Buisson gastroenterologist at Clermont-Ferrand University Hospital explaining what a #biosimilar is"
X Link 2025-04-29T00:32Z [---] followers, [---] engagements
"Severe #asthma can impact people both physically and psychologically. Hear from Prof. Jens Schreiber MD Head of Clinics for Pneumonology at University Hospital Magdeburg discussing the physical and psychological challenges that people living with severe asthma face"
X Link 2025-05-07T05:12Z [---] followers, [---] engagements
"Today we announced our Q1 [----] earnings release. Read full report at: https://bit.ly/4dBPTLc https://bit.ly/4dBPTLc"
X Link 2025-05-09T08:52Z [---] followers, [---] engagements
"Ahead of this year's #WorldIBDDay we spotlight Prof. Mathurin Fumery gastroenterologist at Amiens-Picardie University Hospital who talks about the unmet needs of #IBD patients and how #biosimilars address these challenges. Tune in to find out more"
X Link 2025-05-16T00:27Z [---] followers, [---] engagements
"Safety and efficacy are key when selecting a treatment. Did you know that #biosimilars are regulatory-approved medicines and perform just as well as their reference products Hear from Prof. Anthony Buisson gastroenterologist from Clermont-Ferrand University Hospital sharing his insights on the safety and efficacy of biosimilars"
X Link 2025-05-26T04:42Z [---] followers, [---] engagements
"Join us at #EAACI [----] Visit Booth F30 to learn more about our commitment to allergy care and patient well-being. Lets talk science solutions and a better future for patients. Explore how our science is driving real impact for patients around the world. 🔬"
X Link 2025-06-14T10:57Z [---] followers, [---] engagements
"🌱 Our sustainability journey in Europe has officially begun With the release of our [----] Sustainability Report our European affiliates take a unified step forward under the European Sustainability Reporting Standards (ESRS) framework. This report highlights how we are shaping sustainability strategies around key material topics and reaffirms our commitment to strengthening these efforts for a healthier more sustainable future. 🌿 Stay tuned as each affiliate gradually publishes its individual report on their official website. Read the full report: #ESG https://bit.ly/4kXoN4U"
X Link 2025-06-22T23:48Z [---] followers, [---] engagements
"#Biosimilars submit to strict clinical trials to prove their safety and efficacy. Listen to our interview with Prof. Jrme Avouac rheumatologist at Cochin University Hospital Paris as he explains the key elements that ensure the quality of biosimilars"
X Link 2025-06-25T00:55Z [---] followers, [--] engagements
"Every day individuals worldwide are diagnosed with conditions that require biological therapy. The availability of #biosimilars has significantly facilitated access to essential biologic treatments for patients. Professor Anthony Buisson a gastroenterologist at Clermont-Ferrant University Hospital discusses the critical role biosimilars play in enhancing patient care"
X Link 2025-07-15T00:22Z [---] followers, [---] engagements
"In most cases comprehensive data is required to prove the biosimilarity between #biosimilars and reference products. Hear from Prof. Jrme Avouac a rheumatologist at Cochin University Hospital Paris as he discusses how the safety and effectiveness of biosimilars are ensured"
X Link 2025-08-13T02:05Z [---] followers, [--] engagements
"Ensuring the long-term sustainability of medications is crucial particularly for patients with chronic diseases as these conditions have lifelong impacts. In this video Professor Mathurin Fumery a gastroenterologist at Amiens-Picardie University Hospital explains how #biosimilars can improve long-term access to treatment for patients while alleviating the burden on the healthcare system"
X Link 2025-09-02T00:35Z [---] followers, [---] engagements
"Greetings from Amsterdam #ERSCongress [----] began on Saturday. Come by booth C.03 meet our team see our innovations in #respiratory and learn how we aim to improve patient outcomes with science-driven solutions. 🌍🩺"
X Link 2025-09-29T07:58Z [---] followers, [---] engagements
"With the growing importance of #ESG in the bio industry Celltrion Inc. started full-scale activities to strengthen its ESG strategies. We are proud to support this initiative to care for our planet. 🌏 #Sustainability #Environment #SocialImpact"
X Link 2022-09-02T06:27Z [---] followers, [--] engagements
"BREAKING NEWS: Today Celltrion Healthcare has merged with Celltrion Inc. to enhance its market position and create opportunities for growth. As of today we will deliver up-to-date and unified news in the social space under the name of Celltrion. Stay tuned #DaringtoGoBeyond"
X Link 2023-12-30T05:56Z [---] followers, [---] engagements
"BREAKING NEWS: We are delighted to announce that the @EMA_News #CHMP has adopted a positive opinion recommending the approval of three #biosimilars from Celltrion. This will bring us one step closer to offering the patient-centric treatment for people living with various diseases in Europe. View press release https://bit.ly/3VF4DlG https://bit.ly/3VF4DlG"
X Link 2024-12-16T00:01Z [---] followers, [---] engagements
"Today is #WorldCancerDay. We stand united in the fight against cancer focusing on people-centered care and seeking new ways to make a meaningful impact. Together with the help of advances in #biosimilars we aim to improve access to life-saving treatments for patients worldwide. 🌎 Watch full video at: #UnitedbyUnique https://bit.ly/4gou9mP What exactly is a #biosimilar and how could it expand #cancer treatment options for patients Explore the science behind these therapies in the #RewritingCancer series from @BBCStoryWorks @UICC supported by Celltrion Inc. https://t.co/idB0ev8qJP"
X Link 2025-02-04T01:11Z [---] followers, [---] engagements
"We are heading to our first on-site congress of the year #ECCO2025 Join us in Berlin to learn more about our recent advancements in #IBD care. 📅 Wednesday February [--] Saturday February [--] 📍 Booth [--] Hall 2.2b (Level 2) Messe Berlin"
X Link 2025-02-10T05:20Z [---] followers, [---] engagements
"If you are attending #ECCO2025 dont miss our Meet The Expert session where we will discuss the latest clinical data on treatment in #IBD. Find them at Celltrion booth (Hall 2.2) 📌 Meet Prof. Stefan Schreiber and Dr. Julia Husman on Friday [--] February 15:10-15:40 CET 📌 Meet Prof. Anthony Buisson on Saturday [--] February 10:20-10:50 CET #MeetTheExperts"
X Link 2025-02-14T00:58Z [---] followers, [---] engagements
"Today at #ECCO2025 we presented our latest data which includes multiple post hoc analyses from the LIBERTY study. These insights underscore our commitment to improving patient outcomes through breakthrough #IBD research. View the press release here: https://bit.ly/3Qrhuov https://bit.ly/3Qrhuov"
X Link 2025-02-21T00:01Z [---] followers, [---] engagements
"BREAKING NEWS: We are delighted to announce that the @EU_Commission has approved Celltrions treatment for #rheumatic diseases. This represents a significant advancement in our commitment to people living with autoimmune diseases in Europe. View press release here: https://bit.ly/4kqOPOv https://bit.ly/4kqOPOv"
X Link 2025-02-24T00:10Z [---] followers, [---] engagements
"Celltrion will be attending #EULAR2025 in Barcelona. We will proudly be showcasing our ongoing commitment to advancing scientific progress in addressing the unmet needs of people living with rheumatic diseases. 📅 Wednesday June [--] Saturday June [--] 📍 Booth C5 Hall [--] Fira de Barcelona"
X Link 2025-05-30T01:17Z [---] followers, [---] engagements
"📢 Were excited to announce that Celltrion will join the IBD Practice on Air [----] a webinar series on Inflammatory Bowel Disease (#IBD). Find the details of our symposium session below and dont forget to register 📅 Date: Thursday 5th June Time: 18:45 19:15 CEST (30 min) 🎙 Title: What is new in SC Infliximab 👩⚕ Speaker: Dr. Angela Variola Click to register: https://bit.ly/4muzfCs https://bit.ly/4muzfCs"
X Link 2025-06-04T08:59Z [---] followers, [---] engagements
"Celltrion is heading to the [----] #EAACI Congress Join us as we share our latest efforts in allergy care and reaffirm our commitment to patients worldwide. 📅 When Friday June [--] Monday June [--] 📍 Where Hall [--] Booth F30 Scottish Event Campus (SEC) Glasgow"
X Link 2025-06-09T00:00Z [---] followers, [---] engagements
"Heading to #EULAR2025 Make sure to visit Celltrions booth and explore our latest advances in treating rheumatic diseases 💊🧬 Meet our colleagues learn about our work in immunology and see how were hoping to drive better outcomes for patients worldwide"
X Link 2025-06-12T07:25Z [---] followers, [---] engagements
"Celltrion has released its 2024/25 Sustainability Report 🌍 Discover our continued commitment to sustainability ethical governance and social responsibility. We believe in long-term value through transparency. Together we can build a healthier and more environmentally friendly future. 📎 https://bit.ly/3G9QgkY https://bit.ly/3G9QgkY"
X Link 2025-06-27T01:39Z [---] followers, [---] engagements
"We announced our Q2 [----] earnings release on [--] August. Read full report at: https://bit.ly/4mdkuDy https://bit.ly/4mdkuDy"
X Link 2025-08-07T00:11Z [---] followers, [---] engagements
"Celltrion is proud to make its debut at #EURETINA2025 one of the most influential gatherings in #ophthalmology. 📍 Visit us at Booth 2.D15 & 2.D20 from September [--] at Le Palais des Congrs and join us as we explore innovative solutions in ophthalmology and connect with global retinal specialists. 🔬👁"
X Link 2025-08-26T06:42Z [---] followers, [---] engagements
"Celltrion is stepping into the European eye care scene for the first time. 👁 Join us at our booth to explore our latest innovations in eye care. 💡🔬 Meet our team discover how were expanding in #ophthalmology and see whats next for patient-focused therapies. Come and visit us on the exhibition floor #EURETINA2025"
X Link 2025-09-04T23:57Z [---] followers, [---] engagements
"Celltrion is excited to participate in #EADV Congress [----] Join us at the Paris Convention Centre from September [----] and visit booth F04 to explore our latest dermatological innovations and how we're advancing patient care across Europe. ✨🔍"
X Link 2025-09-10T09:03Z [---] followers, [---] engagements
"Celltrion is proud to join the global respiratory community at #ERSCongress [----] Visit us at booth C.03 in RAI Amsterdam Hall [--] and discover our latest advances in treatments supporting #respiratory care. 🔬"
X Link 2025-09-17T04:38Z [---] followers, [---] engagements
"Were excited to present our latest research at this years #EADV Congress. The clinical outcomes of our products reflect our ongoing dedication to improving the lives of individuals affected by dermatological conditions. Read more https://bit.ly/3VpfD6s https://bit.ly/3VpfD6s"
X Link 2025-09-19T05:07Z [---] followers, [---] engagements
"Were excited to join CPHI Europe [----] Join us at Booth 6.1C70 to meet the Celltrion team and discover how were shaping the future of biopharmaceuticals.💡 #Celltrion #CPHI"
X Link 2025-10-21T00:05Z [---] followers, [--] engagements
"Were excited to join CPHI Europe [----] Join us at Booth 6.1C70 to meet the Celltrion team and discover how were shaping the future of biopharmaceuticals.💡 #Celltrion #CPHI"
X Link 2025-10-21T01:35Z [---] followers, [--] engagements
"We were honored to welcome global #IBD leaders to Celltrions headquarters where they toured our state-of-the-art facilities and shared valuable insights on advancing scientific innovation and enhancing patient care worldwide. During the visit participants experienced Celltrions commitment to innovation and patient centered care exchanging perspectives on how we can continue driving progress in global healthcare together. It was a truly inspiring opportunityto connect collaborate and reaffirm our shared goal of improving access totreatment for patients worldwide. A heartfelt thank you to"
X Link 2025-11-11T01:20Z [---] followers, [--] engagements
"BREAKING NEWS: Were excited to share that the European Commission has granted the label extension for an additional presentation of our #omalizumab #biosimilar. This milestone represents a meaningful contribution to reducing the burden of disease and improving patients quality of life. We will continue our efforts to increase accessibility for patients. - View press release here: https://bit.ly/3LKngmo https://bit.ly/3LKngmo"
X Link 2025-11-18T04:50Z [---] followers, [---] engagements
"BREAKING NEWS: Were proud to share that the European Commission has authorized the worlds first liquid formulation of IV #infliximab This milestone marks an important step forward in reducing the workload of healthcare professionals and enhancing hospital operational efficiency - enabling more focus on patient care. - View press release here: https://shorturl"
X Link 2025-11-18T08:42Z [---] followers, [--] engagements
"BREAKING NEWS: Were proud to share that the European Commission has authorized the worlds first liquid formulation of IV #infliximab This milestone marks an important step forward in reducing the workload of healthcare professionals and enhancing hospital operational efficiency - enabling more focus on patient care. - View press release here: https://shorturl.at/45isq https://shorturl.at/45isq"
X Link 2025-11-20T07:14Z [---] followers, [---] engagements
"Since their introduction #biosimilars have progressively transformed patient perceptions. Prof. Jrme Avouac rheumatologist at Cochin University Hospital Paris describes how biosimilars have gained patients trust throughout the years"
X Link 2025-12-02T00:00Z [---] followers, [--] engagements
"BREAKING NEWS: Were proud to announce that the CHMP has adopted a positive opinion and recommended marketing authorization for autoinjector (pre-filled pen) of our #ustekinumab #biosimilar. This marks an important milestone in offering patients both convenience and practical usability while expanding available treatment options. Find more https://bit.ly/44UOHAH https://bit.ly/44UOHAH"
X Link 2025-12-18T04:58Z [---] followers, [---] engagements
"Celltrion is thrilled to participate in #UEGWeek [----] the premier event in European #gastroenterology From October [--] at Messe Berlin visit booth number [----] to explore our robust #IBD solutions. 🌍🔍 Talk with our experts dive into detailed insights and discover how Celltrion is redefining personalized care for digestive diseases. https://twitter.com/i/web/status/1971385401018610164 https://twitter.com/i/web/status/1971385401018610164"
X Link 2025-09-26T01:24Z [---] followers, [---] engagements
"Celltrion is now participating in UEGW [----] Discover our latest data and insights in the field of gastroenterology by visiting our booth. We look forward to meeting you in person at the congress. Stop by and be part of the conversation shaping the future of gastroenterology. #UEGW2025 #Celltrion #BuiltonTrustDrivingInnovation #Gastroenterology https://twitter.com/i/web/status/1974812274964803896 https://twitter.com/i/web/status/1974812274964803896"
X Link 2025-10-05T12:21Z [---] followers, [---] engagements
"At UEG Week [----] Celltrion presented real-world data on subcutaneous infliximab during a Meet-the-Expert session. Celltrion remains committed to advancing innovative biologics improving access and supporting sustainable healthcare worldwide. View the press release here: http://bit.ly/46VKRr4 http://bit.ly/46VKRr4"
X Link 2025-10-06T10:26Z [---] followers, [---] engagements
"Were proud to announce that Celltrion has been selected as a finalist for the [----] Global Generics & Biosimilars Awards This recognition in the Biosimilar Initiative of the Year category highlights Celltrions leadership in advancing access to high-quality biologics through innovation reliability and sustainable growth. By achieving major regulatory milestones and expanding into new therapeutic areas Celltrion continues to set new standards for excellence in the global biosimilar industry. We remain dedicated to improving treatment access and patient outcomes worldwide through our fully"
X Link 2025-10-14T07:50Z [---] followers, [---] engagements
"Were excited to join CPHI Frankfurt [----] Join us at Booth 6.1C70 to meet the Celltrion team and discover how were shaping the future of biopharmaceuticals.💡 #Celltrion #CPHI"
X Link 2025-10-22T00:56Z [---] followers, [---] engagements
"We announced our Q3 [----] earnings release on [--] November. Read the full report here: https://bit.ly/4hKWfuR https://bit.ly/4hKWfuR"
X Link 2025-11-06T05:12Z [---] followers, [--] engagements
"We were honored to welcome global #IBD leaders to Celltrions headquarters where they toured our state-of-the-art facilities and shared valuable insights on advancing scientific innovation and enhancing patient care worldwide. During the visit participants experienced Celltrions commitment to innovation and patient centered care exchanging perspectives on how we can continue driving progress in global healthcare together. It was a truly inspiring opportunityto connect collaborate and reaffirm our shared goal of improving access totreatment for patients worldwide. A heartfelt thank you to"
X Link 2025-11-11T06:34Z [---] followers, [--] engagements
"Celltrion presented its key strategic priorities and updates on its innovative drug pipeline and therapies alongside its U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference. At the conference the company outlined its strategic direction toward innovative therapeutics building on its deep antibody expertise. This includes plans across antibody-drug conjugates (ADCs) multispecific antibodies (MsAbs). In addition Celltrion presented its strategy to scale U.S. manufacturing and R&D capabilities as part of its long-term growth plan reinforcing supply"
X Link 2026-01-14T05:37Z [---] followers, [--] engagements
"We announced our FY2025 / 4Q [----] earnings release on [--] February. Read the full report here: https://bit.ly/4hKWfuR https://bit.ly/4hKWfuR"
X Link 2026-02-05T01:21Z [---] followers, [--] engagements
"Celltrion is pleased to participate in ECCO Congress [----]. We are honored to take part in this meaningful global congress dedicated to Crohns disease and ulcerative colitis where experts come together to advance discussions in the field of inflammatory bowel disease (IBD). During the congress we invite you to visit Celltrion at Booth #22 and connect with our team. 📌Booth #22 #ECCO #ECCO2026 #ECCOCongress https://twitter.com/i/web/status/2021763950602596431 https://twitter.com/i/web/status/2021763950602596431"
X Link 2026-02-12T01:51Z [---] followers, [--] engagements
"Celltrion is pleased to participate in ECCO Congress [----]. We are honored to take part in this meaningful global congress dedicated to Crohns disease and ulcerative colitis where experts come together to advance discussions in the field of inflammatory bowel disease (IBD). During the congress we invite you to visit Celltrion at Booth #22 and connect with our team. 📌Booth #22 #ECCO #ECCO2026 #ECCOCongress https://twitter.com/i/web/status/2021763950602596431 https://twitter.com/i/web/status/2021763950602596431"
X Link 2026-02-12T01:51Z [---] followers, [--] engagements
"We announced our FY2025 / 4Q [----] earnings release on [--] February. Read the full report here: https://bit.ly/4hKWfuR https://bit.ly/4hKWfuR"
X Link 2026-02-05T01:21Z [---] followers, [--] engagements
"Welcome to the last edition of our #biosimilar video series. Wrapping up the discussion Prof. Anthony Buisson gastroenterologist at Clermont-FerrantUniversity Hospital shares his thoughts on the evolving patient acceptance and perception of biosimilars over the years"
X Link 2026-01-27T03:05Z [---] followers, [--] engagements
"Celltrion presented its key strategic priorities and updates on its innovative drug pipeline and therapies alongside its U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference. At the conference the company outlined its strategic direction toward innovative therapeutics building on its deep antibody expertise. This includes plans across antibody-drug conjugates (ADCs) multispecific antibodies (MsAbs). In addition Celltrion presented its strategy to scale U.S. manufacturing and R&D capabilities as part of its long-term growth plan reinforcing supply"
X Link 2026-01-14T05:37Z [---] followers, [--] engagements
"BREAKING NEWS: Were proud to announce that the CHMP has adopted a positive opinion and recommended marketing authorization for autoinjector (pre-filled pen) of our #ustekinumab #biosimilar. This marks an important milestone in offering patients both convenience and practical usability while expanding available treatment options. Find more https://bit.ly/44UOHAH https://bit.ly/44UOHAH"
X Link 2025-12-18T04:58Z [---] followers, [---] engagements
"Since their introduction #biosimilars have progressively transformed patient perceptions. Prof. Jrme Avouac rheumatologist at Cochin University Hospital Paris describes how biosimilars have gained patients trust throughout the years"
X Link 2025-12-02T00:00Z [---] followers, [--] engagements
"BREAKING NEWS: Were proud to share that the European Commission has authorized the worlds first liquid formulation of IV #infliximab This milestone marks an important step forward in reducing the workload of healthcare professionals and enhancing hospital operational efficiency - enabling more focus on patient care. - View press release here: https://shorturl.at/45isq https://shorturl.at/45isq"
X Link 2025-11-20T07:14Z [---] followers, [---] engagements
"BREAKING NEWS: Were excited to share that the European Commission has granted the label extension for an additional presentation of our #omalizumab #biosimilar. This milestone represents a meaningful contribution to reducing the burden of disease and improving patients quality of life. We will continue our efforts to increase accessibility for patients. - View press release here: https://bit.ly/3LKngmo https://bit.ly/3LKngmo"
X Link 2025-11-18T04:50Z [---] followers, [---] engagements
"We were honored to welcome global #IBD leaders to Celltrions headquarters where they toured our state-of-the-art facilities and shared valuable insights on advancing scientific innovation and enhancing patient care worldwide. During the visit participants experienced Celltrions commitment to innovation and patient centered care exchanging perspectives on how we can continue driving progress in global healthcare together. It was a truly inspiring opportunityto connect collaborate and reaffirm our shared goal of improving access totreatment for patients worldwide. A heartfelt thank you to"
X Link 2025-11-11T06:34Z [---] followers, [--] engagements
"We announced our Q3 [----] earnings release on [--] November. Read the full report here: https://bit.ly/4hKWfuR https://bit.ly/4hKWfuR"
X Link 2025-11-06T05:12Z [---] followers, [--] engagements
"Were excited to join CPHI Frankfurt [----] Join us at Booth 6.1C70 to meet the Celltrion team and discover how were shaping the future of biopharmaceuticals.💡 #Celltrion #CPHI"
X Link 2025-10-22T00:56Z [---] followers, [---] engagements
"Were proud to announce that Celltrion has been selected as a finalist for the [----] Global Generics & Biosimilars Awards This recognition in the Biosimilar Initiative of the Year category highlights Celltrions leadership in advancing access to high-quality biologics through innovation reliability and sustainable growth. By achieving major regulatory milestones and expanding into new therapeutic areas Celltrion continues to set new standards for excellence in the global biosimilar industry. We remain dedicated to improving treatment access and patient outcomes worldwide through our fully"
X Link 2025-10-14T07:50Z [---] followers, [---] engagements
"At UEG Week [----] Celltrion presented real-world data on subcutaneous infliximab during a Meet-the-Expert session. Celltrion remains committed to advancing innovative biologics improving access and supporting sustainable healthcare worldwide. View the press release here: http://bit.ly/46VKRr4 http://bit.ly/46VKRr4"
X Link 2025-10-06T10:26Z [---] followers, [---] engagements
"Celltrion is now participating in UEGW [----] Discover our latest data and insights in the field of gastroenterology by visiting our booth. We look forward to meeting you in person at the congress. Stop by and be part of the conversation shaping the future of gastroenterology. #UEGW2025 #Celltrion #BuiltonTrustDrivingInnovation #Gastroenterology https://twitter.com/i/web/status/1974812274964803896 https://twitter.com/i/web/status/1974812274964803896"
X Link 2025-10-05T12:21Z [---] followers, [---] engagements
"Greetings from Amsterdam #ERSCongress [----] began on Saturday. Come by booth C.03 meet our team see our innovations in #respiratory and learn how we aim to improve patient outcomes with science-driven solutions. 🌍🩺"
X Link 2025-09-29T07:58Z [---] followers, [---] engagements
"Celltrion is thrilled to participate in #UEGWeek [----] the premier event in European #gastroenterology From October [--] at Messe Berlin visit booth number [----] to explore our robust #IBD solutions. 🌍🔍 Talk with our experts dive into detailed insights and discover how Celltrion is redefining personalized care for digestive diseases. https://twitter.com/i/web/status/1971385401018610164 https://twitter.com/i/web/status/1971385401018610164"
X Link 2025-09-26T01:24Z [---] followers, [---] engagements
"Were excited to present our latest research at this years #EADV Congress. The clinical outcomes of our products reflect our ongoing dedication to improving the lives of individuals affected by dermatological conditions. Read more https://bit.ly/3VpfD6s https://bit.ly/3VpfD6s"
X Link 2025-09-19T05:07Z [---] followers, [---] engagements
"#EADV [----] has kicked off in Paris Drop by booth F04 at the Paris Convention Centre to immerse yourself in our latest skin care solutions and clinical breakthroughs. 💡🧴 Connect with our experts explore our contributions to dermatological medicine and discover how we're helping shape the future of skin health"
X Link 2025-09-18T05:50Z [---] followers, [---] engagements
"Celltrion is proud to join the global respiratory community at #ERSCongress [----] Visit us at booth C.03 in RAI Amsterdam Hall [--] and discover our latest advances in treatments supporting #respiratory care. 🔬"
X Link 2025-09-17T04:38Z [---] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing